Cabotegravir: WHO Recommends Injectable Drug for HIV Prevention for the First Time
The injectable drug is still limited but the WHO recommendation urges countries to deliver cabotegravir for HIV prevention.
Source: natureworldnews.com
Stay updated with breaking news from Scientists Develop Potential. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The injectable drug is still limited but the WHO recommendation urges countries to deliver cabotegravir for HIV prevention.
A new study found that HIV prefers immune cells coated with sugar, a breakthrough on determining which specific cells the virus favors of attacking.